Skip to main content

Table 3 Intervention and follow-up effects of clinical assessment

From: Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: results of a randomized controlled trial

Diabetic polineuropathy clinical assessment

Instrument

Control Group

Intervention Group

Intervention effect

Follow-up effect

 

Baseline (a) n = 29

12 weeks (b) n = 29

Baseline (c) n = 26

12 weeks (d) n = 26

24 weeks (e) n = 26

Effect size or median difference (CI 95%)b-d

Effect size or median difference (CI 95%)b-d

MNSI questionnaire (score) a

6 (3)

6 (3)

6¶§ (2)

4 (3)

4 (2)

0.52 (medium)

0.54 (medium)c-d

 

0.54 (medium)c-e

MNSI physical assessment (score) b

4.5 (3; 6.5)

5.5 (2.5; 7)

4.5 (3.0; 6.5)

4.0§ (4.0; 5.0)

5.0§ (5.0; 5.5)

-1.5 [-2.8 a -0.2]

-0.5 [-1.7 a 1.7]c-d

 

0.5 [-0.7 a 1.7]c-e

ABC questionnaire (% of confidence) c

78 (18)

78 (19)

84 (16)

86§ (8)

89§ (8)

0.50 (medium)

0.34 (small)c-d

 

0.21 (small)c-e

Muscle function d

Extensor digitorum longus and brevis

3.5*

4.0

4.0

4.0

4.0§

0.0 [0.0 to 0.0]

0.0 [0.0 to 0.0]c-d

 

(3.0; 4.0)

(3.0;5.0)

(3.3;5.0)

(4.0;4.0)

(3.0;4.0)

 

0.0 [0.0 to 0.0]c-e

Extensor hallucis longus and brevis

4.0

4.0

4.0

4.0

4.0

0.0 [0.0 to 0.0]

0.0 [-0.5 to 0.5]c-d

 

(4.0;5.0)

(4.0;5.0)

(4.0;5.0)

(4.0;5.0)

(4.0;4.0)

 

0.0 [-0.5 to 0.5]c-e

Flexor digitorum brevis

4.0

4.0†‡

4.0

5.0

4.0

-1.0 [-1.0 to -1.0]

0.0 [-0.5 to 0.5]c-d

 

(4.0;5.0)

(3.0;5.0)

(3.0;5.0)

(4.0;5.0)

(4.0;4.0)

 

0.0 [-0.5 to 0.5]c-e

Flexor hallucis brevis

4.0

4.0

4.0

4.0

4.0

0.0 [0.0 to 0.0]

0.0 [0.0 to 0.0]c-d

 

(3.0;5.0)

(3.3;4.8)

(4.0;5.0)

(4.0;5.0)

(4.0;4.0)

 

0.0 [0.0 to 0.0]c-e

Lumbrical

4.0

3.0

4.0

4.0§

3.5§

-1.0 [-1.5 to -.05]

0.0 [-0.9 to 0.9]c-d

 

(3.0;5.0)

(2.0;5.0)

(2.0;5.0)

(3.0;4.8)

(2.3;4.0)

 

0.5 [-0.4 to 0.4]c-e

Interosseous

3.5

3.0

4.0

4.0‡§

3.0§

-1.0 [-1.5 to -0.5]

0.0 [0.5 to 1.5]c-d

 

(2.0;4.0)

(2.0;4.0)

(2.0;5.0)

(3.0;4.0)

(3.0;3.0)

 

1.0 [0.5 to 1.5]c-e

Tibialis anterior

4.5

4.0

4.0

5.0

4.0

-1.0 [-1.0 to -1.0]

0.0 [-0.5 to 0.5]c-d

 

(3.0;5.0)

(4.0;5.0)

(4.0;5.0)

(4.0;5.0)

(4.0;4.0)

 

0.0 [-0.5 to 0.5]c-e

Triceps surae

5.0

5.0

5.0

5.0

5.0

0.0 [0.0 to 0.0]

0.0 [0.0 to 0.0]c-d

 

(4.0;5.0)

(4.0;5.0)

(4.0;5.0)

(5.0;5.0)

(4.0;5.0)

 

0.0 [0.0 to 0.0]c-e

Functional tests e

Ankle flexion

3.5

3.0

4.0

4.0‡¶#

3.0

1.0 [0.5 a 1.5]

0.0 [-0.4 a 2.4]c-d

 

(1.0;4.0)

(1.0;4.0)

(1.0;4.0)

(3.0;4.0)

(1.0;4.0)

 

1.0 [-0.4 a 2.4]c-e

Ankle extension

4.0

4.0

4.0¶§

4.0

4.0§

0.0 [0.0 a 0.0]

0.0 [0.0 a 0.0]c-d

 

(4.0;4.0)

(4.0;4.0)

(4.0;4.0)

(4.0;4.0)

(4.0;4.0)

 

0.0 [0.0 a 0.0]c-e

Toes flexion

4.0

3.5

4.0¶#

4.0‡¶

4.0

0.5 [0.0 a 1.0]

0.0 [-0.5 a 0.5]c-d

 

(3.0;4.0)

(3.0;4.0)

(3.0;4.0)

(4.0;4.0)

(4.0;4.0)

 

0.0 [-0.5 a 0.5]c-e

Toes extension

4.0*

4.0

4.0

4.0ত

4.0§

0.0 [0.0 a 0.0]

0.0 [0.0 a 0.0]c-d

 

(3.3;4.0)

(4.0;4.0)

(4.0;4.0)

(4.0;4.0)

(4.0;4.0)

 

0.0 [0.0 a 0.0]c-e

  1. *differences between baselines (p < 0.05).
  2. differences between baseline and 12 weeks for the control group (p < 0.05).
  3. two different conditions from each other (p < 0.05).
  4. §different conditions from each other between follow-up comparisons (p < 0.05).
  5. differences between baseline and 12 weeks for the intervention group (p < 0.05).
  6. amean and standard deviation; maximum score of 13 (symptoms of DPN).
  7. bmedian and interquartile interval; maximum score of 10 (tactile and vibration sensitivity, calcaneal reflex and foot inspection).
  8. cmean and standard deviation; maximum of 100% (% of confidence referred by the patients).
  9. dmedian and interquartile interval; muscle function test gradation (Kendall et al., 2005):
  10. 5:holds test position against maximal resistance.
  11. 4:holds test position against moderate resistance.
  12. 3:holds test position against gravity.
  13. 2:able to move through full ROM with gravity eliminated.
  14. 1:no visible movement, palpable or observed tendon prominence/flicker contraction.
  15. 0:no palpable or observable muscle contraction.
  16. eClassification of foot function (Palmer and Epler, 1990):
  17. 4:normal functionality.
  18. 3:reasonable functionality.
  19. 2:little functionality.
  20. 1:absent functionality.